Thermo Fisher Scientific Inc. (TMO) Unveils Bioprocess Design Center to Develop Life-Changing Therapies

FierceBiotechAnalysts ‘shaking heads’ after Regeneron melanoma drug fails to beat Keytruda in phase 3 trial

BioPharma DiveUnlocking more value from mature drug products through strategic outsourcing

GCCGCC Hydroxypropyl Methylcellulose Market Report 2026–2034 | Construction and Pharma Trends - vocal.media

FierceBiotechArdent Health taps Fujifilm’s AI-enabled patient imaging platform

FierceBiotechExecuting biomarker-driven oncology trials

10x Genomics NewsAssessing 10x Genomics (TXG) Valuation After Q1 2026 Results And Rising AI Trading Interest - simplywall.st

Lonza NewsLonza Group AG stock (CH0013841017): focus shifts to growth after strategic review and margin reset - AD HOC NEWS

eLifeSurging towards a better understanding of ovulation

Thermo FisherThermo Fisher Scientific Inc. (TMO) Unveils Bioprocess Design Center to Develop Life-Changing Therapies - Yahoo Finance

Samsung BiologicsKorean Pharma, Biotech Firms Post Strong Q1 Sales While Profitability Diverges - thelec.net

Charles RiverNeoGenomics and Charles River Laboratories Shares Plummet, What You Need To Know - Yahoo Finance